Soon after word got out about an FBI probe into uBiome’s billing practices, the microbiome testing startup put its general counsel in charge as the co-founders stepped aside from their roles as co-CEOs. John Rakow, the interim CEO, vowed to “cooperate fully with government authorities and private payors to satisfactorily resolve the questions that have been raised.”
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,